Association of T-cadherin levels with the response to neoadjuvant chemotherapy in locally advanced breast cancer. - Wikidata - wikimedia - TriplyDB

Association of T-cadherin levels with the response to neoadjuvant chemotherapy in locally advanced breast cancer.

Association of T-cadherin levels with the response to neoadjuvant chemotherapy in locally advanced breast cancer.

http://www.wikidata.org/entity/Q37706693

about

Association of T-cadherin levels with the response to neoadjuvant chemotherapy in locally advanced breast cancer.

http://www.wikidata.org/entity/Q37706693

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Association of T-cadherin leve ...... ocally advanced breast cancer.

@en

Association of T-cadherin leve ...... ocally advanced breast cancer.

@nl

type

label

Association of T-cadherin leve ...... ocally advanced breast cancer.

@en

Association of T-cadherin leve ...... ocally advanced breast cancer.

@nl

prefLabel

Association of T-cadherin leve ...... ocally advanced breast cancer.

@en

Association of T-cadherin leve ...... ocally advanced breast cancer.

@nl

P1433

Q37706693-208057D1-D115-4E3F-8DF3-CB89E330A043

P1476

Q37706693-9DA3ADF3-F5B8-4663-817D-C04C01D9BD40

P2093

Q37706693-20140B9A-5AC6-422D-9131-4A9798D00B4E

Q37706693-91281907-BFE3-4F0E-9694-8F2BC4B5FE0B

Q37706693-99FC32BB-1774-45E9-8E46-A37E81E004A1

Q37706693-D53555C3-3DAD-4CA2-A0D5-448A920F62FA

P2860

Q37706693-038098E2-DF8D-4C9D-B414-6A6F28A3B24F

Q37706693-055BBE8D-1A8C-483D-9EA7-3437A438C871

Q37706693-05A365E9-865E-438A-B968-48AFC62F2AF3

Q37706693-0B5EB310-FB2A-4610-90DA-74D5E248D843

Q37706693-12894B81-FB3B-4826-BDE7-6B3919376FE3

Q37706693-15E8F211-49A6-4621-91ED-F799E52BF852

Q37706693-20C94332-8355-451F-8C80-4F9B3EE6599C

Q37706693-2C351312-36B3-468D-B6EA-55205E057F16

Q37706693-37B5452D-F4F3-4744-9F24-976D07E161F4

Q37706693-3BD41505-5043-4534-8A8A-D8BC89259B49

P304

Q37706693-9F747E6B-96BE-40C9-B50C-46F04B418668

P31

Q37706693-D0615B2F-9EEE-496D-8242-BE0B6C588C6B

P356

Q37706693-B10F1BBD-2833-4B9B-952C-BCC994D9C580

P407

Q37706693-A375912A-F24E-46EE-BB22-76E44D538405

P433

Q37706693-0BA72E28-CB64-48EC-81CB-DDD9E3385EC0

P478

Q37706693-6FB4FC68-82A3-4EAD-ACC6-488F783C7E94

P577

Q37706693-BDED7A0E-7204-4F8E-A6AE-25A573B78A79

P698

Q37706693-5DCDE87C-8B66-4202-B026-38B89532D760

P921

Q37706693-F1D95C92-CCB0-42D0-88E0-41D7D7F5E42E

P932

Q37706693-2E61BA6E-980F-4E8A-9521-CD8F435EEE19

P356

ONCOTARGET.14630

P1433

P1476

Association of T-cadherin leve ...... ocally advanced breast cancer.

@en

P2093

Dedi Kong

http://www.w3.org/2001/XMLSchema#string

Jie Yang

http://www.w3.org/2001/XMLSchema#string

Liang Li

http://www.w3.org/2001/XMLSchema#string

Mei-Hong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells

T-cadherin structures reveal a novel adhesive binding mechanism

Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin

BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

ER, PgR, Ki67, p27(Kip1), and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide

Estrogen receptor (ER), progesterone receptor (PR), and HER2 expression pre- and post- neoadjuvant chemotherapy in primary breast carcinoma: a single institutional experience.

Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy.

Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay.

Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration.

P304

13747-13753

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.14630

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28099918

http://www.w3.org/2001/XMLSchema#string

P921

P932

5355134

http://www.w3.org/2001/XMLSchema#string